FVRL

Favrille and MyMedicalRecords.com, Inc. Announce Merger Agreement - 11/10 - 07:00 AM ET

Favrille Announces Execution of Non-binding Term Sheet for a Merger Transaction - 10/24 - 07:00 AM ET

Favrille Announces Receipt of Nasdaq Letter - 08/22 - 04:05 PM ET

Favrille Announces Receipt of Nasdaq Letters - 07/15 - 04:05 PM ET

Favrille Declines Further On News Of Job Cuts - 05/29 - 09:42 AM ET

Favrille Announces Workforce Reduction - 05/29 - 07:30 AM ET

Favrille Plunges In Pre-Market On Negative Trial Results Of Specifid - 05/27 - 08:50 AM ET

Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma - 05/27 - 07:30 AM ET

Favrille Inc. (FVRL) Corporate Event Announcement Notice - 05/09 - 09:14 PM ET

Favrille Inc. (FVRL) Corporate Event Announcement Notice - 05/08 - 09:48 PM ET

Favrille Reports First Quarter 2008 Financial Results - 05/08 - 04:05 PM ET

FVRL: Q1 Earnings Call @ 17:00 ET Today [delayed] - 05/08 - 02:29 PM ET

Favrille Inc. (FVRL) Corporate Event Announcement Notice - 05/02 - 09:08 PM ET

Favrille to Host Conference Call and Live Webcast to Discuss First Quarter 2008 Financial Results on May 8, 2008 - 05/01 - 07:00 AM ET

Favrille Inc. (FVRL) Corporate Event Announcement Notice - 04/27 - 08:39 PM ET

Favrille Inc. (FVRL) Corporate Event Announcement Notice - 04/26 - 08:55 PM ET

The SI Report: Progressive Following on Favrille Inc. - 04/10 - 04:30 AM ET

Favrille Announces Data Cutoff For Phase 3 Registration Trial Of Specifid; Unblinding Of Data Expected In June - 04/09 - 09:19 AM ET

FVRL: Data Cutoff for Phase 3 Registration Trial of Specifid(TM) - 04/09 - 08:54 AM ET

Favrille Reaches Data Cutoff Date For Phase 3 Registration Trial Of Specifid Following Rituxan - Quick Facts - 04/09 - 06:49 AM ET

Page 1 of 2     1  2      Previous  |  Next

<< Back to Stock Index